This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kadlec, K.
Right arrow Articles by Schwarz, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kadlec, K.
Right arrow Articles by Schwarz, S.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, December 2004, p. 4903-4906, Vol. 48, No. 12
0066-4804/04/$08.00+0     DOI: 10.1128/AAC.48.12.4903-4906.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Antimicrobial Susceptibility of Bordetella bronchiseptica Isolates from Porcine Respiratory Tract Infections

Kristina Kadlec,1 Corinna Kehrenberg,1 Jürgen Wallmann,2 and Stefan Schwarz1*

Institut für Tierzucht, Bundesforschungsanstalt für Landwirtschaft (FAL), Neustadt-Mariensee,1 Bundesamt für Verbraucherschutz und Lebensmittelsicherheit (BVL), Berlin, Germany2

Received 7 July 2004/ Returned for modification 6 August 2004/ Accepted 9 August 2004

MICs for 349 Bordetella bronchiseptica isolates from respiratory tract infections of swine were determined by broth microdilution. The lowest MIC at which 90% of isolates tested are inhibited (MIC90) was that of tetracycline and enrofloxacin (0.5 µg/ml), whereas the highest MIC90s were those of tilmicosin and cephalothin (32 µg/ml) as well as streptomycin (256 µg/ml).

* Corresponding author. Mailing address: Institut für Tierzucht der Bundesforschungsanstalt für Landwirtschaft (FAL), Höltystr. 10, 31535 Neustadt-Mariensee, Germany. Phone: 49-5034-871-241. Fax: 49-5034-871-246. E-mail: stefan.schwarz{at}fal.de.

Antimicrobial Agents and Chemotherapy, December 2004, p. 4903-4906, Vol. 48, No. 12
0066-4804/04/$08.00+0     DOI: 10.1128/AAC.48.12.4903-4906.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Kadlec, K., Wiegand, I., Kehrenberg, C., Schwarz, S. (2007). Studies on the mechanisms of {beta}-lactam resistance in Bordetella bronchiseptica. J Antimicrob Chemother 59: 396-402 [Abstract] [Full Text]  
  • Kadlec, K., Kehrenberg, C., Schwarz, S. (2007). Efflux-mediated resistance to florfenicol and/or chloramphenicol in Bordetella bronchiseptica: identification of a novel chloramphenicol exporter. J Antimicrob Chemother 59: 191-196 [Abstract] [Full Text]  
  • Kadlec, K., Kehrenberg, C., Schwarz, S. (2006). tet(A)-mediated tetracycline resistance in porcine Bordetella bronchiseptica isolates is based on plasmid-borne Tn1721 relics. J Antimicrob Chemother 58: 225-227 [Full Text]  
  • Kadlec, K., Kehrenberg, C., Schwarz, S. (2005). Molecular basis of resistance to trimethoprim, chloramphenicol and sulphonamides in Bordetella bronchiseptica. J Antimicrob Chemother 56: 485-490 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»